← Leaderboards
Xiaoming Dai
Beth Israel Deaconess Medical Center
$1,086,768
Attributed
$1,086,768
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249K · FY2021–25$250K$187.5K$125K$62.5K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,086,768 · 2
By mechanism
R00$747,000 · 1
K99$339,768 · 1
Top collaborators
No co-investigators on record.
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Kermit L Carraway$11,333,366
- Alex Toker$16,651,718
- Laura E Benjamin$10,185,711
- Ramesh K Ganju$10,257,043
- Dong-Er Zhang$30,254,830
Others in their field
Other Emerging Leaders on “Endometrial Carcinoma”
- Kara Lavidge McKinley · Harvard University$3,378,617
- Alanna K Rahm · Geisinger Clinic$3,038,251
- Kimberly A. Bertrand · Boston University Medical Campus$2,747,227
- Ashley S. Felix · Ohio State University$2,533,810
- Shujie Yang · University Of Iowa$2,440,269
- Rachelle L Crescenzi · Vanderbilt University Medical Center$2,398,771
Research focus
Endometrial CarcinomaAwardEctopic ExpressionBasic ScienceBiochemicalBiological ProcessAutomobile DrivingAccountingBreast TumorigenesisCancer BiologyCancer DiagnosticsCancer TherapyCareerCell GrowthCell PhysiologyBreastBreast Cancer TreatmentColorectal CancerDesignDeubiquitinating EnzymeDeubiquitinationDrosophila GenusDruggable TargetExperimental Study
Grant awards (5)
Elucidating a Novel Mechanism for LATS1/2 in Suppressing Tumorigenesis$249,000
R00 · FY2025 · CA · contact PI
Elucidating a Novel Mechanism for LATS1/2 in Suppressing Tumorigenesis$249,000
R00 · FY2024 · CA · contact PI
Elucidating a Novel Mechanism for LATS1/2 in Suppressing Tumorigenesis$249,000
R00 · FY2023 · CA · contact PI
Elucidating a Novel Mechanism for LATS1/2 in Suppressing Tumorigenesis$169,884
K99 · FY2022 · CA · contact PI
Elucidating a Novel Mechanism for LATS1/2 in Suppressing Tumorigenesis$169,884
K99 · FY2021 · CA · contact PI